SCHEMBL8619962

SCHEMBL8619962

COc1ccc2c(C(=O)NC(=N)N)cc(-c3ccccc3C)nc2c1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 2/20 0.42
KMT2A Q03164 6/20 0.42
MEN1 O00255 3/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
ALDH1A1 P00352 6/20 0.40
HPGD P15428 5/20 0.40
MAPT P10636 3/20 0.40
HTT P42858 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GPR55 Q9Y2T6 1/20 0.40
KDM4E B2RXH2 4/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
NPSR1 Q6W5P4 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8619729 0.96 CA2 (0.43) TACR3KMT2AMEN1CA2CA9
SCHEMBL8619742 0.92 TACR3 (0.43) TACR3KMT2AMEN1CA2CA9
SCHEMBL8617847 0.90 TACR3 (0.42) TACR3KMT2AMEN1CA2CA9
SCHEMBL8613395 0.88 PDE10A (0.51) TACR3KMT2AMEN1CA2CA9
SCHEMBL8614875 0.87 PDE10A (0.52) TACR3KMT2AMEN1ALDH1A1HPGD
SCHEMBL8618478 0.86 THRB (0.39) TACR3KMT2AMEN1CA2CA9
SCHEMBL8620849 0.86 TACR3 (0.39) TACR3KMT2AMEN1CA2CA9
SCHEMBL8618908 0.85 MAPT (0.44) TACR3KMT2AMEN1CA2CA9
SCHEMBL8619166 0.85 TACR3 (0.40) TACR3KMT2AMEN1CA2CA9
SCHEMBL8620350 0.84 CA2 (0.43) TACR3KMT2AMEN1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed